Answers are grounded in this paper and cite their sources.
Lacto- N -triose II (LNTII), lacto- N -tetraose (LNT), and lacto- N -neotetraose (LNnT) are key neutral human milk oligosaccharides (HMOs) with significant physiological functions. In cell factory-based synthesis, glycosyltransferases are rate-limiting enzymes, enhancing the activity of which is, therefore, crucial for efficient synthesis of HMOs. To address this issue, we developed a high-throughput screening method based on a UDP-glucose regeneration-coupled colorimetric reaction. As a case study, we applied this screening method for the directed evolution of β-1,3- N -acetylglucosamine transferase in Saccharomyces cerevisiae ( S. cerevisiae ), resulting in a mutant strain that doubled LNnT production. Additionally, by enhancing the metabolic flux of the heterologous pathway, we further elevated the total LNnT titer to 1.29 g/L, setting a new record for LNnT production in S. cerevisiae. Our study demonstrates the effectiveness of the high-throughput screening method based on UDP-glucose regeneration-coupled disaccharide transferase colorimetric assay and provides a new strategy for improving the biosynthetic efficiency of HMOs that release UDP during the synthesis process.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: